Linde India Ltd.
NSE: LINDEINDIANIFTY500
₹7,141.50+6.3%1Y
Last updated 02:56:57 IST· Public market feed (~15 min delay during market hours)
Linde India Ltd.: A 30-second snapshot
Linde India (₹7,352) is the Indian subsidiary of global industrial-gas leader Linde plc, operating in the Chemicals sector. The stock trades 16.5% higher over 12 months, above both its 50-DMA (₹7,182) and 200-DMA (₹6,439), at a trailing PE of 106.4x — the highest among 6 tracked sector peers. Fundamental consistency is limited: a quality score of 53/100, FCF positive in only 2 of available years, rising debt, and ROE data available for only 1 year.
P/E
106.4
Forward P/E
90.3
ROE
—
Debt / Equity
—
Profit Margin
+23.5%
Div. Yield
+0.1%
5Y ROE > 15%
1/5
5Y FCF > 0
2/5
Quality
46/100
Recent context
- ·No news articles were retrieved for LINDEINDIA in the current data cycle — the absence of news flow means recent catalysts, regulatory updates, or corporate actions cannot be assessed from this run.
- ·Analyst coverage is very thin at 3 analysts with no consensus rating number available, providing limited visibility into how institutional research is positioned on the stock.
- ·The stock sits between key technical levels: nearest support at ₹6,945 (5.5% below current price) and nearest resistance at ₹7,464 (1.5% above), with the 52-week high at approximately ₹8,049.
Strengths
- +Price momentum is positive across timeframes: +16.5% over 12 months and +13.3% over 3 months, with the stock currently 8.7% below its 52-week high and RSI at 49.9 (neutral zone).
- +The 23.52% profit margin is above the median of the 6 tracked Chemicals peers and the forward PE of 90.3x implies some analyst expectation of near-term earnings expansion relative to the trailing figure.
- +Revenue has grown at a 13.1% 5-year CAGR, suggesting a sustained top-line expansion rather than a one-time event, which partially supports the elevated valuation premium.
- +Quality score of 53/100 ranks 3rd of 6 tracked Chemicals peers (PIDILITIND 66, SOLARINDS 61), placing Linde India in the upper half of available peer comparisons on this composite metric.
Weaknesses
- −Fundamental consistency score is 10/100, with ROE above 15% in only 1 of available years and FCF positive in only 2 of available years — earnings durability is difficult to confirm from the available record.
- −Debt trend is reported as rising, and both the D/E ratio and ROE point estimates are unavailable, making a full solvency picture impossible with the current data.
- −At 106.4x trailing PE, Linde India trades at a 14% premium to the next-highest peer (SOLARINDS 93.5x) and at a 3.7x multiple to COROMANDEL (28.2x), the most valuation-stretched position in the tracked peer set.
- −The 676.4% 5-year earnings growth almost certainly reflects recovery from a depressed base; the 10/100 consistency score and incomplete ROE history make it difficult to assess whether the profit expansion is structural.
Open questions
- ?Is the 676.4% five-year earnings growth driven by a structural improvement in Linde India's contract mix and pricing power, or does it primarily reflect normalisation from a low-base period — and what does the trajectory look like in the most recent 2-3 years alone?
- ?Given that FCF was positive in only 2 of available years and the debt trend is rising, how is the company funding its capital expenditure, and at what pace is net debt growing relative to operating cash flow?
- ?At a trailing PE of 106.4x — the highest among tracked sector peers — what earnings growth rate and over what horizon would be required to bring the multiple in line with peers such as SOLARINDS (93.5x) or PIDILITIND (61.0x)?
- ?How does Linde India's relationship with its parent, Linde plc, affect pricing of industrial gases, contract tenures, and potential delisting or open-offer risk, and has that relationship changed materially in recent years?
Peer comparison: Chemicals
Ranks 3 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| LINDEINDIA | Linde India Ltd.You're viewing | 106.4 | — | 53 |
| Industry avg | across 5 peers | 51.7 | +21.1% | 45 |
| PIDILITIND | Pidilite Industries Ltd. | 61.0 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 93.5 | +31.3% | 61 |
| SRF | SRF Ltd. | 43.5 | +13.8% | 41 |
| COROMANDEL | Coromandel International Ltd. | 28.2 | +15.6% | 30 |
| PIIND | PI Industries Ltd. | 32.6 | — | 25 |
Technical state
Current price
₹7,352.00
SMA 50
₹7,181.63
SMA 200
₹6,438.58
RSI (14)
49.9 (neutral)
From 52w high
-8.7%
1Y return
+16.5%
3M return
+13.3%
50-DMA
Above
200-DMA
Above
Algorithmic support levels
₹6,944.50
₹6,558.00
₹6,510.00
Algorithmic resistance levels
₹7,464.00
₹7,515.00
₹8,049.00
Risk flags
- highFundamental persistence is very weak: consistency score 10/100, ROE above 15% in only 1 of available years, FCF positive in only 2 of available years, and debt trend is rising. ROE and D/E point estimates are unavailable, preventing a direct solvency assessment.
- mediumPE of 106.4x is the highest among 6 tracked Chemicals sector peers (SOLARINDS 93.5x, PIDILITIND 61.0x, SRF 43.5x, PIIND 32.6x, COROMANDEL 28.2x), embedding substantial future earnings growth expectations into the current price.
- medium5-year earnings growth of 676.4% almost certainly reflects a very low base period; with a consistency score of 10/100 and ROE unavailable for most years, the durability of the 23.52% profit margin cannot be assessed from the available data.
- lowNews feed returned 0 articles — no recent sentiment signal is available. Analyst coverage is very thin at 3 analysts with no consensus rating reported. All 5 sector peers are missing 1-year price change data, limiting relative momentum comparison.
Cross-section contradictions
- Price is up 16.5% over 12 months and only 8.7% below its 52-week high, trading above both the 50-DMA (₹7,182) and 200-DMA (₹6,439), yet the fundamental consistency score is 10/100 with ROE above 15% in just 1 of available years — price momentum and fundamental quality persistence are diverging.
- 5-year earnings growth of 676.4% alongside a 23.52% profit margin suggests a dramatic turnaround, yet FCF was positive in only 2 of available years and the debt trend is rising — earnings recovery and cash-generation quality are not yet aligned.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days